Soricimed Biopharma inc. débute la conception et le développement d'un conjugué biologique de médicament
July 18, 2012 07:30 ET
|
Soricimed Biopharma inc.
TORONTO, ONTARIO--(Marketwire - 18 juillet 2012) - Soricimed Biopharma Inc, société privée spécialisée dans le développement de thérapies et d'outils de...
Soricimed Biopharma Inc. Commences the Design and Development of Biologic Drug Conjugates
July 18, 2012 07:30 ET
|
Soricimed Biopharma Inc.
TORONTO, ONTARIO--(Marketwire - July 18, 2012) - Soricimed Biopharma Inc., a private company developing novel cancer therapeutics and diagnostics, is collaborating with Mount Allison...
Soricimed Biopharma Inc. Attending 2012 BIO International
June 14, 2012 07:30 ET
|
Soricimed Biopharma Inc.
TORONTO, CANADA--(Marketwire - June 14, 2012) - Soricimed Biopharma Inc., a private company developing novel cancer therapeutics and diagnostics, will be exhibiting with the Atlantic...
Soricimed Biopharma Inc. Receives IND Clearance to Commence Phase I Trial of New Cancer Drug
May 29, 2012 07:30 ET
|
Soricimed Biopharma Inc.
TORONTO, CANADA--(Marketwire - May 29, 2012) - Soricimed Biopharma Inc., a private company developing novel cancer therapeutics and diagnostics, is pleased to announce that the...